Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Arend

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Immunobiology|January 1, 1980
An auto-reactive A-like ovarian determinant distinct from xeno-reactive A-like structuresP Arend
European Journal of Immunology|November 1, 1971
Observations on different origins of "naturally" occurring antibodiesP Arend
The Journal of Clinical Investigation|November 1, 1991
Interleukin 1 receptor antagonist. A new member of the interleukin 1 familyW P Arend
Advances in Internal Medicine|January 1, 1995
Inhibiting the effects of cytokines in human diseasesW P Arend
Arthritis and Rheumatism|April 1, 1997
The pathophysiology and treatment of rheumatoid arthritisW P Arend
Arthritis and Rheumatism|April 20, 2001
Physiology of cytokine pathways in rheumatoid arthritisW P Arend
Lancet (London, England)|January 16, 1993
IL-1 antagonism in inflammatory arthritisW P Arend
Arthritis and Rheumatism|February 22, 2002
Arthritis & Rheumatism in 2000William P. Arend
Cytokine & Growth Factor Reviews|September 11, 2002
The balance between IL-1 and IL-1Ra in diseaseWilliam P Arend
The Journal of Rheumatology. Supplement|September 19, 2002
The mode of action of cytokine inhibitorsWilliam P Arend
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Immunobiology|January 1, 1980
An auto-reactive A-like ovarian determinant distinct from xeno-reactive A-like structuresP Arend
European Journal of Immunology|November 1, 1971
Observations on different origins of "naturally" occurring antibodiesP Arend
The Journal of Clinical Investigation|November 1, 1991
Interleukin 1 receptor antagonist. A new member of the interleukin 1 familyW P Arend
Advances in Internal Medicine|January 1, 1995
Inhibiting the effects of cytokines in human diseasesW P Arend
Arthritis and Rheumatism|April 1, 1997
The pathophysiology and treatment of rheumatoid arthritisW P Arend
Arthritis and Rheumatism|April 20, 2001
Physiology of cytokine pathways in rheumatoid arthritisW P Arend
Lancet (London, England)|January 16, 1993
IL-1 antagonism in inflammatory arthritisW P Arend
Arthritis and Rheumatism|February 22, 2002
Arthritis & Rheumatism in 2000William P. Arend
Cytokine & Growth Factor Reviews|September 11, 2002
The balance between IL-1 and IL-1Ra in diseaseWilliam P Arend
The Journal of Rheumatology. Supplement|September 19, 2002
The mode of action of cytokine inhibitorsWilliam P Arend
Pageof 17